SEARCH LISTED COMPANY

Any AUS or NZ company

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ACUVAX LIMITED (ACU)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
PLUS CONNECT LIMITED09/05/2018
ACTIVISTIC LIMITED13/05/201509/05/2018
ACUVAX LIMITED05/12/200813/05/2015
AVANTOGEN LIMITED31/05/200505/12/2008
AUSTRALIAN CANCER TECHNOLOGY LIMITED04/05/200131/05/2005
EXODUS MINERALS LIMITED14/08/199704/05/2001
MINERALS MINING AND METALLURGY LIMITED14/08/1997

Shareholder links

Our website ranking of ACU: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Security Transfer Australia Pty Ltd, 770 Canning Highway Applecross WA 6153
Tel : +61 3 9628 2200
Fax : +61 8 9315 2233
RegistryWebsite RegistryEmail

Company details

Address: Suite 2, 16 Ord Street, WEST PERTH, WA, AUSTRALIA, 6005
Tel:  08 9429 2900 Fax: 08 9486 1011

Date first listed: 25/08/1971
Company Secretary: Roland Berzins
Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Cancer drug development

The securities of Activistic Limited (the "Company") will be reinstated to official quotation as from 10 am EDST on 15 May 2015, following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX Listing Rules. 86,338,988 ordinary shares fully paid Security Code ACU

13/05/2015

name changed to Activistic Limited

13/05/2015

issues a supplementary prospectus

15/04/2015

releases an amended prospectus timetable

08/04/2015

lodges a prospectus for an offer of 40,000,000 Shares at an issue price of $0.10 each to raise $4,000,000 before costs with provision for oversubscriptions of up to an additional 20,000,000 Shares at the same issue price to raise up to a maximum of $6,000,000 before costs

26/03/2015

the 1 for 10 securities consolidation has now been finalised.

20/03/2015

we understand that on or about this date the company consolidated its shares 1 for 10

19/03/2015

The securities of Acuvax Limited (the "Company") will be suspended from official quotation prior to the commencement of trading on Thursday 12 March 2015, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU

12/03/2015

The suspension of trading in the securities of Acuvax Limited (the "Company") will be lifted from the commencement of trading tomorrow, Tuesday, 26 August 2014, following receipt of an announcement regarding completion of a capital raising. Security Code: ACU

25/08/2014

resolutions considered at the general meeting were passed unanimously on a show of hands

30/07/2014

a General Meeting of the Company will be held at Suite 4, 16 Ord Street West Perth, Western Australia on 30 July 2014 at 10:00AM (WST)

01/07/2014

releases to the market a copy of the Company's corporate presentation that will be delivered to investors and their brokers during the upcoming investor presentations

24/06/2014

company has executed a binding heads of agreement to acquire 100 % of all rights and title in all the issued capital Activistic Pty Ltd

23/06/2014

confirms terms for a placement to sophisticated and professional investors to raise up to $600,000. Up to 1,200,000,000 shares will be placed to investors at an issue price of $0.0005 per share to raise a total of $600,000

20/06/2014

The ASX has made enquiries of the Company in that it has asked of the Company: ï‚· to provide a market update as to its status; ï‚· the plans the Company may have for trading in its securities to resume; and ï‚· the Company's progress in implementing those plans In response the Company has advised the market that Acuvax has appointed Mr Alex Bajada to its board of Directors

30/05/2014

the results of the Annual General Meeting in accordance with listing rule 3.13.2 and section 251AA of the Corporations Act. - resolutions where passed unanimously on a show of hands

27/11/2013

the Annual General Meeting of Shareholders of Acuvax Limited will be held at the Suite 4, 16 Ord Street, West Perth on Wednesday 27 th November 2013 commencing at 2:00 PM WST

24/10/2013

releases Annual Report to shareholders

27/09/2013

The Boards of Acuvax Ltd and Biolife Science Ltd are pleased to announce that the exposure period for the Acuvax Offer to raise up to $5m to fund Phase 2 trials of its HERVaxx cancer immunotherapy has now ended and that the Offer is now open. The Prospectus and Application Form are available on the Acuvax website at: www.acuvax.com.au

04/04/2013

we understand that on or about this date the company consolidated its shares 1 for 200

22/03/2013

The securities of Acuvax Limited (the "Company") will be suspended from official quotation from the commencement of trading tomorrow, Friday 22 March 2013, pending the outcome of a resolution at the Company" general meeting to approve a change in the scale of the Company" activities. The Company" securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU

21/03/2013

name changed from Avantogen Limited

05/12/2008

ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Ian MurieNon Exec Chairman21/10/2010
    Kevin BaumNon Exec Director29/08/2014
    Roland BerzinsDirector27/01/2012

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Nigel LeeDirector17/10/201426/11/2014
    Alex BajadaNon Exec Director23/05/201429/08/2014
    Anton UvarovNon Exec Director10/10/201314/03/2014
    Alistair JoblingDirector16/10/201210/10/2013
    Keong ChanDirector19/11/201015/10/2012
    Lloyd FlintDirector19/11/201027/01/2012
    William ArdreyChairman, CEO29/08/200608/02/2011
    Yvonne FoongDirector13/12/200619/11/2010

    Date of first appointment, title may have changed.